Myopia Market Is Expected To Grow During The Study Period (2019-2032), DelveInsight | Key Companies: Nevakar, Sydnexis, and Several Others

DelveInsight's Myopia Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Myopia Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Myopia Market report covers emerging drugs, current treatment practices, market share of individual therapies, and the current forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best opportunities and assess the underlying potential of the market.

Myopia Overview
Myopia (also known as Nearsightedness), occurs when the eye grows too long from front to back. The eye lens starts focusing the images in front of the retina instead of focusing on the retina. Therefore, people with Myopia have well near vision but poor distance vision. The distant objects appear blurry while the near ones appear normal. Undiagnosed cases may lead to headaches and strains to struggle for the clear visualization of the things in the distance. The signs and symptoms for Myopia include squinting, feeling fatigued when driving or playing sports headaches and strain.

Get access to a free copy of our latest sample report @ https://www.delveinsight.com/sample-request/myopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key takeaways from the Myopia Market Report
• According to a study conducted by Dyanne et al., Myopia occurs in 10% of the general population but is more common in older adults; the prevalence is 20% in those older than 60 years and 50% in those older than 70 years. The increased prevalence in older adults is related to peripheral vascular disease, immunologic disorders, and diabetes mellitus.
• A study by Vitale et al., in the United States, found that the prevalence of moderate Myopia, defined as between -2.00 D and -7.9 D, nearly doubled (from 4% in 1971-1972 to 22.4% in 1999-2004), and that the prevalence of high Myopia, which was defined as more than 8.00 D of Myopia for this study, had increased eightfold during the same period (from 0.2% to 1.6%).
• As per the study by Yotsukura et al., the prevalence of Myopia was 5% among those aged 6-11 years and 94.9% among those aged 12-14 years, and the prevalence of high Myopia was 4.0% among those aged 6-11 years and 11.3% among those aged 12-14 years.

Myopia Market
The Myopia market size is anticipated to increase during the study period owing to the increasing incident population and rising awareness of the Myopia Market in the 7MM. The expected launch of emerging therapies and the research and development activities of pharmaceutical companies will also fuel the market growth during the forecast period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Myopia Market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives a thorough detail of the Myopia Market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Myopia Market Outlook
Currently, the market does not hold any approved product to slow the progression or treatment of Myopia. The main treatment options of single vision spectacle lenses, contact lenses, and refractive surgery do not slow the accompanying eye growth or retard the physiological changes associated with excessive axial elongation.

Myopia Market Insights
The most common way to treat Myopia is with corrective eyeglasses or contact lenses, which refocus light onto the retina. The use of corrective eyeglasses or contact lenses can be best suggested and identified by the medical professional depending on the need and the requirement of the patients. In younger children, a technique called retinoscopy helps the eye doctor determine the correction required.

Download Free Sample Report of the Myopia Treatment and Key Players @ https://www.delveinsight.com/sample-request/myopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Myopia Epidemiology
The epidemiology section covers insights into the historical and current Myopia Market patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Myopia Market Drugs & Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Myopia Market or expected to get launched in the market during the study period. The analysis covers Myopia market uptake by drugs; patient uptake by therapies; and sales of each drug.

Report's Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Myopia Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies. Unmet needs in the Myopia include therapies that are oral, anthracycline sparing and deliverable in resource-limited settings. Another major unmet need is the relapse and refractory cases in the patients given treatment with Doxil.

Browse More Related Reports of the Myopia Market Research Reports @ https://www.delveinsight.com/report-store/myopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Myopia Emerging Therapies
Many novel therapies are in the late stage of development, targeting a more effective approach for the treatment of Myopia. Upcoming therapies have the potential to start a new era in its treatment if and once approved.

Myopia Companies
• Nevakar
• Sydnexis, and Several Others

Myopia Drugs
• NVK-002
• SYD-101, and Several Others

Read Full Research Report of the Myopia Market Forecast Report @ https://www.delveinsight.com/report-store/myopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of content
1. Key Insights
2. Executive Summary
3. Competitive Intelligence Analysis
4. Market Overview at a Glance
5. Disease Background and Overview
6. Patient Journey
7. Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Myopia Market Treatment
11. Marketed Products
12. Emerging Therapies
13. Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

Consult with our Business Expert @ https://www.delveinsight.com/report-store/myopia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

This release was published on openPR.